Open-Label, Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia.

Trial Profile

Open-Label, Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Nov 2012

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Dyslipidaemias; Hypercholesterolaemia
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Kowa Pharmaceutical
  • Most Recent Events

    • 26 Jan 2010 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
    • 26 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Sep 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top